Impact of Treatment With TNF-α Inhibitors for Hidradenitis Suppurativa During the COVID-19 Pandemic. uri icon

Overview

publication date

  • February 24, 2021

Research

keywords

  • Anti-Inflammatory Agents
  • COVID-19
  • Hidradenitis Suppurativa
  • Tumor Necrosis Factor-alpha

Identity

Scopus Document Identifier

  • 85101762026

Digital Object Identifier (DOI)

  • 10.1177/1203475421997058

PubMed ID

  • 33625899

Additional Document Info

volume

  • 25

issue

  • 4